Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibodies
Biotech
Regeneron backs $75M series A for antibody upstart Infinimmune
The raise will support two eczema drugs that Infinimmune plans to push into the clinic next year.
Darren Incorvaia
Aug 11, 2026 8:00am
Merck enlists antibody hunter Infinimmune for $838M biobucks
Mar 31, 2026 8:00am
J&J, Royalty to co-fund $500M autoimmune antibody program
Mar 30, 2026 10:07am
After $1B fundraise, Xaira breaks silence on AI work
Mar 17, 2026 2:52pm
Agilent makes $950M move to acquire Biocare
Mar 11, 2026 3:00pm
BioAtla lays off 70% of workforce, seeks buyers for antibodies
Mar 2, 2026 9:40am